-
First-trimester combined screening for trisomy 21 at 8-13 weeks.
Wright D, Spencer K, Kagan K, Tørring N, Petersen O, Christou A, Kallikas J, Nicolaides K.
Ultrasound Obstet Gynecol 2010;36:404-11. -
Early vaginal bleeding has no impact on markers used in first trimester aneuploidy screening.
Spencer K, Spencer CE, Stamatopoulou A, Staboulidou I, Nicolaides KH.
Prenat Diagn 2010;30:547-50. -
First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers.
Spencer K, Staboulidou I, Nicolaides KH.
Prenat Diagn 2010;30:235-40. -
Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.
Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;35:662-70. -
Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH.
Prenat Diagn 2010;30:216-23. -
Chorionic villus sampling at 11 to 13 weeks of gestation and hypertensive disorders in pregnancy.
Khalil A, Akolekar R, Pandya P, Syngelaki A, Nicolaides K.
Obstet Gynecol 2010;116:374-80. -
Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing.
Kagan K, Staboulidou I, Cruz JJ, Wright D, Nicolaides K.
Ultrasound Obstet Gynecol 2010;36:542-7. -
Effect of temperature on the measurement of free beta-hCG and PAPP-A concentration.
Cruz JJ, Cruz G, Minekawa R, Maiz N, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:141-6. -
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia.
Ashoor G, Maiz N, Rotas M, Kametas NA, Nicolaides KH.
Prenat Diagn 2010;30:1032-8. -
Maternal thyroid function at 11-13 Weeks of gestation in women with hypothyroidism treated by thyroxine.
Ashoor G, Rotas M, Maiz N, Kametas NA, Nicolaides KH.
Fetal Diagn Ther 2010;28:22-27. -
Maternal thyroid function at 11-13 weeks of gestation.
Ashoor G, Kametas NA, Akolekar R, Guisado J, Nicolaides KH.
Fetal Diagn Ther 2010;27:156-63. -
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death.
Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH.
Thyroid 2010;20:989-93. -
Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R, Pérez Penco JM, Skyfta E, Rodríguez Calvo J, Nicolaides KH.
Fetal Diagn Ther 2010;27:72-7. -
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K, Cowans NJ, Avgidou K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:637-43. -
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.
Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS.
Ultrasound Obstet Gynecol 2006;27:13-7. -
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:151-5.